CANADA LIFE ASSURANCE Co Purchases 17,606 Shares of CorVel Co. (NASDAQ:CRVL)

CANADA LIFE ASSURANCE Co boosted its position in CorVel Co. (NASDAQ:CRVL - Free Report) by 200.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 26,409 shares of the business services provider's stock after acquiring an additional 17,606 shares during the period. CANADA LIFE ASSURANCE Co owned 0.05% of CorVel worth $2,938,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Marshall Wace LLP bought a new position in CorVel in the 4th quarter valued at about $671,000. Jump Financial LLC boosted its position in shares of CorVel by 219.2% during the fourth quarter. Jump Financial LLC now owns 9,987 shares of the business services provider's stock valued at $1,111,000 after buying an additional 6,858 shares during the last quarter. Walleye Capital LLC bought a new stake in CorVel during the fourth quarter worth $730,000. Mariner LLC raised its position in CorVel by 214.3% in the 4th quarter. Mariner LLC now owns 2,637 shares of the business services provider's stock valued at $293,000 after buying an additional 1,798 shares during the last quarter. Finally, Barclays PLC lifted its stake in CorVel by 209.3% during the 4th quarter. Barclays PLC now owns 49,409 shares of the business services provider's stock valued at $5,497,000 after acquiring an additional 33,432 shares in the last quarter. Institutional investors and hedge funds own 51.36% of the company's stock.

Insider Buying and Selling at CorVel

In related news, Director Alan Hoops sold 10,200 shares of CorVel stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total value of $1,187,178.00. Following the completion of the transaction, the director now directly owns 118,213 shares in the company, valued at approximately $13,758,811.07. The trade was a 7.94 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Steven J. Hamerslag sold 10,000 shares of the firm's stock in a transaction on Thursday, February 6th. The stock was sold at an average price of $123.48, for a total value of $1,234,800.00. Following the completion of the transaction, the director now directly owns 314,000 shares of the company's stock, valued at $38,772,720. The trade was a 3.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 48,723 shares of company stock worth $5,757,140 over the last ninety days. 47.57% of the stock is currently owned by company insiders.

CorVel Price Performance

Shares of NASDAQ CRVL traded up $2.95 during midday trading on Friday, reaching $111.92. The company's stock had a trading volume of 23,693 shares, compared to its average volume of 118,838. The stock has a market capitalization of $5.75 billion, a P/E ratio of 66.06 and a beta of 0.94. The firm has a 50 day moving average price of $110.34 and a 200-day moving average price of $115.68. CorVel Co. has a 12-month low of $76.53 and a 12-month high of $128.61.

CorVel (NASDAQ:CRVL - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of CorVel from a "hold" rating to a "buy" rating in a research report on Friday, April 18th.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.